| Date | Form | Description | Docs | XBRL | Pages |
| 09/08/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 08/24/17 | 8-K | Current report filing |
|
3 | |
| 08/18/17 | 8-K | Current report filing |
|
2 | |
| 08/08/17 | DEF 14A | Definitive proxy statements |
|
37 | |
| 07/25/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/25/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/21/17 | 8-K | Current report filing |
|
3 | |
| 07/12/17 | 8-K | Current report filing |
|
3 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 |
Latest News & Events
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...